Hone Health has secured $228 million in a new funding round. The total consists of $28 million in equity from a Series A round and $200 million in growth capital provided by General Catalyst’s Customer Value Fund. This follows a previous $33 million Series A round announced in January 2025, bringing the company's total equity funding to $65 million.

The investment round was led by MarcyPen, a firm formed in December 2024 through the merger of Marcy Venture Partners and Pendulum Holdings. Other participants include Kinship Ventures, Hanwha, Gannet Capital, humbition, and Comma Capital. Individual investors include the Jonas brothers, Kelly Rowland, Marcello Hernandez, Braxton Berrios, Quentin Dolan, Kyle Samani, and Halle Tecco.

The company currently employs approximately 450 staff members, including physicians, and operates exclusively in the United States. As of January 2025, Hone Health reported having treated 55,000 patients. The platform integrates diagnostic testing, physician-led care, and AI-powered insights to provide health monitoring services.

Hone Health plans to allocate the new capital toward the development of its Longevity OS, expansion into metabolic care and PCOS treatment, and the scaling of clinical trials. The company also intends to commercialize medicines and expand its diagnostic capabilities. Additionally, the firm is publicly launching its concierge membership service, Hone Black.